Furthermore, CCL21/CCR7 was also found to promote cancer cell migration into microlymphatic vessels in breast cancer[19], pancreatic tumor[20], lung adenocarcinoma [21], and esophageal squamous cell carcinoma[22]. Here, CCL21 is linked to breast cancer.